Dab tsi yog qhov tseem ceeb ntawm Bioglutide NA-931 peptide?

complex peptide molecules nrog amazing multi -receptor kev ua haujlwm profiles tseem raug pom nyob rau hauv niaj hnub kev tshawb fawb metabolic. Cov tuam txhab tshuaj thiab pab pawg kawm tshawb fawb tau txaus siab rauTom ntej: Bioglutide NA-931 peptide, uas yog ib qho ntawm cov kev xaiv kho tshiab no. Cov khoom tshiab no yog ib kauj ruam loj rau hauv peb txoj kev nkag siab ntawm peptide-raws li molecules tuaj yeem hloov ntau yam txheej txheem metabolic tib lub sijhawm. Cov kws tshawb fawb thiab cov tuam txhab tshuaj tab tom nrhiav cov tshiab metabolic modulators tau kawm ntau thiab ntau ntxiv txog cov khoom tshwj xeeb ntawm cov tshuaj no uas ua rau nws sib nrug los ntawm lwm cov kev kho tib yam nkaus xwb -. Peptides tuaj yeem tiv thaiv kab mob lom, ua rau lawv nrov. Bioglutide NA-931 peptide muab cov kws tshawb fawb ib qho cuab yeej los tshuaj xyuas cov txheej txheem metabolic nyuaj. Cov tshuaj no cov yam ntxwv tseem ceeb yog qhov tseem ceeb rau kev tshawb fawb txog metabolic, kev txhim kho tshuaj, thiab kev kho tshuaj tshiab. Hauv qhov kev tshawb fawb ntxaws no, qhov peptide qhov tshwj xeeb, kev ua haujlwm, thiab kev siv tswv yim hauv kev tshawb fawb tshuaj tam sim no raug tshuaj xyuas.

Peb muabTom ntej: Bioglutide NA-931, thov xa mus rau lub vev xaib hauv qab no kom paub meej specifications thiab cov ntaub ntawv khoom.

Khoom siv:https://www.kpeptide.com/bodybuilding-peptide/bioglutide-na-931.html

Bioglutide NA-931 yog ib qho complex synthesized peptide uas cuam tshuam nrog metabolic hormone receptors. Kev tshawb fawb peptide chemistry Advanced tsim cov tebchaw uas koom nrog glucose homeostasis, kev siv hluav taws xob, thiab kev hloov pauv metabolic qhia txoj hauv kev tsim cov tshuaj no. Amino acid sequences nyob rau hauv cov qauv tsim txhim kho stability, bioavailability, thiab receptor-binding piv rau ntuj peptides.

Ntawm cov kev tshawb fawb metabolic categorization systems, peptide no yog ib qho tshwj xeeb ntau -agonist molecule. Nws ua haujlwm ntawm incretin receptors thiab txoj hauv kev loj hlob, tsis zoo li ib qho - cov hom tshuaj. Nws ua raws li lub cev kev sib koom ua ke ntawm cov teeb meem metabolic, qhov twg ntau cov tshuaj hormones ua haujlwm ua ke kom muaj zog sib npaug thiab metabolic homeostasis. Cov tshuaj no hu ua "tom ntej- tiam" metabolic modulators los ntawm pab pawg tshawb fawb vim tias lawv tuaj yeem kho ntau yam metabolic tsis ua haujlwm nrog ib qho chaw molecular.

Cov tshuaj categorization ntawm Bioglutide NA-931 peptide suav nrog nws cov keeb kwm hluavtaws thiab cov qauv hloov kho. Cov tshuaj hloov pauv ua kom cov enzymatic degradation tsis kam, lom ib nrab ntawm lub neej, thiab cov qauv faib cov ntaub so ntswg. Cov qauv no tso cov tshuaj nyob rau hauv qeb ntawm hloov peptides rau kev siv tshuaj. Kev nkag siab txog qhov kev faib tawm no pab pawg kws kho mob thiab tshawb fawb soj ntsuam qhov kev siv tau, txoj hauv kev txhim kho, thiab teeb meem kev tswj hwm.

Nws lub tswv yim tshiab multi-receptor kev sib cuam tshuam txheej txheem txhais Bioglutide NA-931 peptide. Qhov kev sib xyaw no muaj kev sib raug zoo rau ntau lub tshuab receptor pib ua haujlwm sib koom ua ke cov lus teb uas ib leeg - cov tshuaj tsis tuaj yeem. Lub multi-receptor profile modulates metabolism ntawm incretin, glucagon, thiab insulin zoo li txoj hauv kev loj hlob. Qhov kev sib xyaw ua ke no cuam tshuam txog kev tswj hwm cov metabolism hauv qhov nyuaj, qhov twg ntau lub teeb liab sib cuam tshuam dynamically.

Peptide binding affinities sib txawv ntawm cov receptor hom, muab ib tug sib npaug ua kom cov qauv uas zoo li tej yam ntuj tso tshuaj hormones, raws li kev tshawb fawb. Thaum txhawb txoj hauv kev txaus los ua rau muaj qhov tshwm sim hauv metabolic, qhov kev xaiv ua kom pom qhov profile no tsis txhob overstimulation. Lub teb chaws txoj kev khi cov cheeb tsam txheeb xyuas cov kev sib haum xeeb ntawm cov neeg txais txiaj ntsig, tso cai rau kev koom tes nrog cov metabolically cuam tshuam receptor subtypes. Kev xaiv yog ib qho kev txhim kho loj dua ua ntej ntau yam -cov txheej txheem agonist uas feem ntau ua rau cov qauv ua kom tsis muaj kev cia siab.

Tshaj li agonism, ntau -kev ua haujlwm receptor modulates receptor signaling. Hauv qee qhov xwm txheej metabolic, Bioglutide NA-931 peptide tuaj yeem tau txais txiaj ntsig los ntawm cov cim qhia hauv qab ntawm txoj kev sib txawv ntawm cov ligands ntuj. Qhov sib xyaw ua ke sib txawv receptor kev sib cuam tshuam profile ua rau nws muaj txiaj ntsig zoo rau kev kawm txog kev sib koom ua ke ntawm cov teeb liab metabolic. Cov kws tsim tshuaj lag luam tsim cov tshuaj sib xyaw ua ke lossis tom ntej - cov txheej txheem metabolic modulators tau txais txiaj ntsig los ntawm ntau qhov receptor feature.

GLP-1 Receptor Engagement thiab Insulin Secretion Modulation

Tom ntej: Bioglutide NA-931 peptidecuam ​​tshuam nrog GLP-1 receptors, pib intracellular signaling pathways txhawb cov piam thaj-nyob ntawm insulin secretion los ntawm pancreatic beta hlwb. Qhov kev cuam tshuam ntawm cov piam thaj no txo ​​qis kev pheej hmoo ntawm hypoglycemia. Cov peptide's GLP-1 kev ua haujlwm tseem cuam tshuam rau beta cell loj hlob thiab ciaj sia, ua kom cov txheej txheem tiv thaiv kab mob pancreatic beta hlwb nyob rau hauv kev ntxhov siab metabolic. Txhim khu kev ruaj ntseg piv rau tej yam ntuj tso GLP-1 ua rau lub sij hawm signaling ua si. Cov qauv kev sib raug zoo tshwm sim los ntawm qee cov amino acid residues haum rau hauv lub hnab ris receptor binding, nrog kev hloov kho hloov kho kinetics thaum khaws cia receptor ua kom muaj peev xwm.

GIP Receptor Interaction thiab Metabolic Coordination

Bioglutide NA-931 peptide khi rau GIP receptors feem ntau pom muaj nyob rau hauv pancreatic beta hlwb thiab cov ntaub so ntswg adipose, koom tes nrog kev nqus cov khoom noj nrog metabolic adaptation. Qhov kev sib cuam tshuam no txhawb nqa insulin secretion synergistically nrog GLP-1 receptor kev ua haujlwm. Tshaj li qhov cuam tshuam ntawm pancreatic, cov compound hloov cov ntaub so ntswg adipose metabolism thiab lub zog cia txoj hauv kev los ntawm GIP receptor activation. Cov peptide qeeb qeeb kinetics rau GIP receptors piv rau ntuj GIP, uas tshwm sim los ntawm kev hloov pauv ntawm molecular, cuam tshuam rau lub sijhawm qis qis thiab kev siv zog, muaj txiaj ntsig zoo hauv qee qhov kev cuam tshuam ntawm metabolic.

Glucagon Receptor Modulation thiab Kev Siv Hluav Taws Xob

Bioglutide NA-931 peptide cuam tshuam nrog glucagon receptors feem ntau nyob hauv daim siab cov ntaub so ntswg, tswj cov piam thaj ntau lawm, fatty acid oxidation, thiab kev siv zog. Receptor activation txhawb lub siab cov piam thaj tso zis thaum tib lub sijhawm ua kom lipid oxidation. Lub compound zoo li txhim kho cov lus teb thermogenic thiab tag nrho cov kev siv hluav taws xob. Qhov sib npaug ntawm glucagon thiab incretin receptor activation tsim cov metabolic profile hais txog kev tswj cov piam thaj thiab lub zog homeostasis, paub qhov txawv ntawm cov peptide no los ntawm incretin-tsuas yog tsom cov tebchaw los ntawm kev sib koom ua ke metabolic.

IGF-1 Pathway Influences thiab Anabolic Signaling

Bioglutide NA-931 peptide cuam tshuam nrog IGF-1 txoj hauv kev, ntxiv qhov loj me ntawm anabolic rau nws qhov profile metabolic. IGF-1 signaling yog qhov tseem ceeb rau kev loj hlob ntawm cov ntaub so ntswg, protein synthesis, thiab metabolic adaptation. Qhov kev sib txuas no cuam tshuam rau lub cev muaj pes tsawg leeg, tshwj xeeb tshaj yog cov ntaub so ntswg khaws cia thaum lub sijhawm metabolic. IGF-1 txoj hauv kev ua kom txhawb nqa cov protein synthesis thiab kho cov leeg nqaij, tiv thaiv kev poob phaus cuam tshuam nrog qee qhov kev cuam tshuam metabolic. Kev sib xyaw ua ke ntawm anabolic signaling nrog kev tswj hwm metabolic sawv cev rau kev sib koom ua ke ntau dua rau kev tshawb fawb txog kev siv metabolic.

Cov qauv kev hloov kho txhim kho qhov ncauj nqus

Bioglutide NA-931 peptide suav nrog kev hloov pauv molecular txhim kho qhov ncauj bioavailability, hais txog qhov nyuaj hauv kev kho peptide. Kev hloov kho tshuaj ua rau muaj kev tiv thaiv rau digestive enzymes, tshwj xeeb tshaj yog proteases uas sai sai degrade pa peptide bonds. Txhim kho daim nyias nyias permeability tau los ntawm kev hloov kho hydrophobic ua kom yooj yim rau txoj hnyuv epithelial cell transit. Cov compound zoo li cuam tshuam nrog cov neeg thauj khoom tshwj xeeb peptide qhia ntawm cov hnyuv epithelial hlwb, muaj peev xwm txhim kho kev noj qab haus huv. Qhov ncauj bioavailability nyob rau hauv ib tug multi-receptor peptide sawv cev rau cov tshuaj chemistry tseem ceeb nce qib.

Central Nervous System Penetration thiab Hypothalamic Signaling

Tom ntej: Bioglutide NA-931 peptidenthuav tawm lub hauv paus paj hlwb nkag mus, nkag mus rau hypothalamic neurons tswj kev noj zaub mov kom tsawg thiab lub zog sib npaug. Qhov kev ua haujlwm hauv nruab nrab no tshwm sim los ntawm cov ntshav ncaj qha- lub paj hlwb barrier hla los yog ntawm peripheral paj hlwb txoj hauv kev sib txuas lus nrog cov chaw noj qab haus huv hypothalamic. Receptor activation nyob rau hauv lub hypothalamus zoo li yuav txo tau noj tsav thiab txhim khu satiety signals. Txoj cai tswj hwm kev noj qab haus huv hauv nruab nrab no ua tiav cov txiaj ntsig peripheral metabolic, tsim cov lus teb sib koom ua ke hais txog ob qho tib si lub cev thiab kev coj tus cwj pwm ntawm lub zog sib npaug.

Neurohormonal Integration thiab Feeding Behavior Modulation

Bioglutide NA-931 peptide cuam tshuam rau kev noj zaub mov tus cwj pwm txuas ntxiv tshaj qhov qab los noj mov kom hloov pauv txoj hauv kev khoom plig thiab kev nyiam zaub mov. Cov compound zoo li cuam tshuam rau dopaminergic thiab serotoninergic systems koom nrog hauv hedonic noj. Kev noj qab haus huv tshwm sim nthuav tawm ob qho kev hloov pauv sai ntawm cov zaub mov noj los ntawm kev qhia txog neural pathway thiab kev txo kom tsawg los ntawm kev ua kom ntev receptor. koob tshuaj - teb kev sib raug zoo qhia tau hais tias noj tshuaj los ntawm kev qab los noj mov. Ua ke qab los noj mov thiab peripheral metabolic cuam tshuam tsim muaj ntau yam sib xyaw txhawb nqa kev tshawb fawb txog metabolic.

Kev Siv Hluav Taws Xob Txhim Kho thiab Thermogenic Activation

Bioglutide NA-931 peptide cuam tshuam rau kev siv hluav taws xob thiab cov txheej txheem thermogenic, uas cuam tshuam rau kev tshawb fawb metabolic. Los ntawm cov ntaub so ntswg thiab lub hlwb ua haujlwm, cov khoom zoo li ua rau kom so metabolic. Kev siv hluav taws xob ntau dua cuam tshuam rau kev sib npaug ntawm lub zog, tsim kom muaj kev teeb tsa metabolic uas siv lub zog ntawm khw muag khoom. Cov kev ua thermogenic hloov xim av thiab muaj peev xwm dawb adipose cov ntaub so ntswg xim av. Ob qho tib si nce cua sov thiab calorie hlawv. Kev hloov pauv hauv cov ntaub so ntswg adipose mitochondria thiab uncoupling protein synthesis nce kev siv zog. Cov peptide's receptors txhawb txoj kev taw qhia uas pab mitochondria txhim kho thiab cais tawm ntawm txoj kev ua pa, raws li kev tshawb fawb. Cov kev ua ntawm tes no ua rau cov pa oxygen thiab carbon dioxide tsim, qhia txog kev metabolism sai. Cov ntaub ntawv tseeb no pab cov kws tshawb nrhiav txhim kho cov metabolism hauv kev hloov pauv thiab hloov kho thermogenesis kuaj. ntau cov ntaub so ntswg tau txais ntau yam thermogenic teebmeem. Lawv yog tshwj xeeb tshaj yog pom nyob rau hauv metabolically noj qab haus huv cov ntaub so ntswg adipose. Activating xim av adipose cov ntaub so ntswg, uas generates tshav kub kom tso tawm zog, yog pab tau. Cov tshuaj yuav ua rau xim av dawb adipose ntaub so ntswg, ntxiv txheej ntxiv. Nws tuaj yeem hloov kho cov ntaub so ntswg adipose zoo metabolically. Vim nws cov ntaub so ntswg tshwj xeeb, peptide tau txais txiaj ntsig zoo rau kev tshawb fawb txog roj ntsha biology thiab hloov pauv cov metabolism.

Lean Mass Preservation Thaum Metabolic Interventions

Qhov nrhiav tau ntawdTom ntej: Bioglutide NA-931 peptidepab tswj cov nqaij ntshiv thoob plaws hauv metabolic hloov yog qhov tseem ceeb. Ib tug xov tooj ntawm metabolic modulators uas tsim lub zog imbalance poob rog thiab nqaij. Ua ke IGF-1 txoj hauv kev ua haujlwm nrog cov cim anabolic, cov tshuaj zoo li txo qis qis qis los ntawm kev nyiam cov ntaub so ntswg adipose los ntawm cov leeg nqaij. Rau kev tshawb fawb uas yuav tsum tau tswj xyuas cov ntaub so ntswg ua haujlwm, qhov kev xaiv no muaj txiaj ntsig zoo vim nws tsuas yog hloov cov chaw hauv lub cev. Ua kom lean loj yuav xav tau kom muaj protein ntau synthesis thiab txo cov protein ntau hauv cov leeg pob txha. Raws li txoj hauv kev anabolic raug cuam tshuam, peptide tsim lub xeev hormonal uas pab cov leeg tuav cov protein txawm tias lub zog qis. Kev sib koom ua ke ntau cov kev taw qhia rau hauv ib qho kev kho mob molecule pab cov protein-sparing. Cov kws tshawb fawb kawm txog kev kho mob metabolic nyiam cov tshuaj uas hloov lub cev muaj pes tsawg leeg es tsis hnyav. Cov tshuaj exerts cuam tshuam rau cov leeg nqaij ntau dhau. Cov leeg thiab cov metabolism kuj tseem cuam tshuam. Cov leeg nqaij muaj zog yog qhov tseem ceeb rau kev noj qab haus huv hauv metabolic vim tias cov leeg pob txha pov tseg cov piam thaj thiab tswj cov metabolism. Cov kws tshawb fawb tau pom tias peptide tuaj yeem ua rau cov leeg nqaij ntau dua insulin-rhiab thiab metabolically hloov pauv, pab lawv tswj cov piam thaj. Cov leeg nqaij ua haujlwm nce ntxiv thiab cov txiaj ntsig muaj txiaj ntsig txhim kho cov kab mob metabolic.

Adipose ntaub so ntswg Remodeling thiab Metabolic Health Markers

Cov teebmeem ntawm bioglutide NA-931 peptide ntawm cov ntaub so ntswg adipose mus dhau kev rog. Kev hloov pauv cov ntaub so ntswg adipose zoo yog ntawm cov txiaj ntsig no. Cov tshuaj no txo ​​cov adipocytes, ua rau kom cov ntshav ntws mus rau cov ntaub so ntswg adipose, thiab txo cov roj cia inflammatory indicators. Cov ntaub so ntswg adipose zoo no ua rau muaj txiaj ntsig zoo rau cov qhab nia metabolic txawm tias cov rog rog tsawg. Kev txhim kho ntawm cov ntaub so ntswg noj qab haus huv yog qhov tseem ceeb rau kev tshawb fawb metabolic. Kev hloov pauv hauv adipogenesis, rog cia, thiab cov metabolism hauv adipocytes induce adipose ntaub so ntswg reorganization. Cov peptide kev sib cuam tshuam nrog cov receptors hloov ntau cov txheej txheem adipocytes ntawm tes, txhim kho cov ntaub so ntswg ua haujlwm. Txo qhov loj ntawm adipocytes txhim kho insulin rhiab heev thiab txo qhov mob, uas yog cov cim qhia kev noj qab haus huv. Cov kws tshawb nrhiav tuaj yeem nkag siab zoo dua li cas cov tshuaj hloov pauv cov metabolism hauv cov ntaub so ntswg adipose kom cuam tshuam rau tag nrho lub cev los ntawm kev nkag siab txog cov teebmeem no. Lwm qhov khoom muaj txiaj ntsig zoo yog tias nws hloov pauv cov ntaub so ntswg faib. Cov peptide muaj qhov cuam tshuam loj tshaj plaws ntawm cov roj visceral, uas txuas nrog cov teeb meem metabolic. Anatomical tshwj xeeb txhais tau hais tias cov tshuaj yuav tsom mus rau cov metabolism-ua phem rau cov rog cia. Cov teebmeem no yog qhov tseem ceeb rau cov kws tshawb fawb tshawb xyuas cov ntaub so ntswg adipose thiab cov kab mob metabolic los txiav txim seb cov ntaub so ntswg qhov chaw cuam tshuam li cas rau kev noj qab haus huv metabolic.

CovTom ntej: Bioglutide NA-931 peptideyog ib qho cuab yeej kawm nyuaj nrog lub peev xwm los cuam tshuam nrog ntau yam receptors, ua kom bioavailable ntawm qhov ncauj, pab tswj kev tshaib kev nqhis hauv lub hlwb, thiab txhawb rau txhua qhov kev hloov pauv hauv metabolic. Cov compound tuaj yeem ua haujlwm nrog GLP-1, GIP, glucagon, thiab IGF-1 txoj hauv kev tib lub sijhawm. Qhov no ua rau cov tshuaj tiv thaiv metabolic uas sib xyaw ua ke thiab cuam tshuam qhov nyuaj ntawm lub cev. Kev kho mob Peptide muaj qee qhov teeb meem uas yuav tsum tau kho. Cov qauv kev hloov pauv uas ua rau lawv ruaj khov dua thiab txhim kho membrane permeability yog ib txoj hauv kev ua qhov no. Cov teebmeem ntawm lub hauv nruab nrab paj hlwb ntxiv kev coj cwj pwm rau kev tswj cov metabolism. Cov khoom no txawv ntawm ib lub hom phiaj metabolic modulators vim nws pab nrog kev hloov pauv hauv lub cev muaj pes tsawg leeg, xws li ua kom cov nqaij ntshiv thiab kho cov nqaij rog.

Cov kws tshawb fawb tuaj yeem siv cov cuab yeej muaj txiaj ntsig los kawm txog kev sib raug zoo hauv metabolic uas sib txuas ntau txoj hauv kev metabolic rau hauv ib qho chaw molecular. Cov tuam txhab uas kawm txog cov metabolism, tsim tshuaj, thiab tuaj nrog cov tshuaj tshiab xav tias qhov sib xyaw no tseem ceeb heev rau kev kawm paub siv cov txheej txheem tom ntej - tiam tom ntej. Bioglutide NA-931 peptide tseem muaj kev txaus siab rau cov tuam txhab tshuaj, pab pawg tshawb fawb biotechnology, thiab kev cog lus tsim kho thiab tsim cov tuam txhab nrhiav cov tshiab metabolic modulators. Cov yam ntxwv tshwj xeeb uas tau saib hauv qhov kev tshawb fawb no qhia tias yog vim li cas.

BLOOM TECH yog kev pom zooTom ntej: Bioglutide NA-931 peptideqhov chaw uas muab cov lag luam kws tshuaj, cov koom haum tshawb fawb biotechnology, thiab cov koom haum cog lus tsim kho thiab tsim khoom (CDOs) nkag mus rau kev tshawb fawb -qib peptide compounds uas tuaj nrog cov ntaub ntawv tshuaj ntsuam xyuas tag nrho. Peb cov chaw tsim khoom 100,000-square-meter yog GMP- ntawv pov thawj thiab tau pom zoo los ntawm US-FDA, EU, PMDA, thiab CFDA. Qhov no txhais tau hais tias qhov zoo ib txwm ruaj khov thiab ua tau raws li cov qauv kev cai txawv teb chaws. Peb tau ua haujlwm nrog cov organic synthesis thiab tshuaj intermediates rau ntau tshaj 12 xyoo, thiab peb tuaj yeem pab koj txav koj cov kev tshawb fawb metabolic rau pem hauv ntej los ntawm kev muab kev txhawb nqa rau koj, cov lus qhia txog kev tswj hwm, thiab cov saw hlau ruaj ntseg. Peb txoj kev lees paub zoo suav nrog peb theem kev kuaj xyuas: kev tshuaj xyuas ntawm cov nroj tsuag, sab hauv QA / QC departments, thiab cov koom haum ywj pheej. Qhov no ua kom paub tseeb tias cov khoom specifications txhawb koj cov hom phiaj kev tshawb fawb. BLOOM TECH tus qauv kev pabcuam ib-nres suav nrog tus nqi meej, tsim nyog tus nqi, cov lus cog tseg rau lub sijhawm raug, thiab kev lis kev cai tshem tawm cov ntaub ntawv tag nrho nyob rau hauv ib qho chaw, tag nrho hauv peb qhov kev sib koom ua ke ERP platform. Hu rau peb cov kws tshaj lij pab neeg ntawmSales@bloomtechz.comlos tham txog yuav ua li cas peb cov kev tshawb fawb -qib peptide muab kev pab cuam tuaj yeem pab koj txoj kev tshawb fawb metabolic thiab kev txhim kho tshuaj.

1. Smith JA, Williams RK, Thompson DL. Multi-receptor agonist peptides hauv kev tshawb fawb metabolic: cov txheej txheem thiab kev siv. Phau ntawv Journal of Peptide Science. 2022; 28(4): 245-262.

2. Chen LM, Rodriguez-Pascual F, Martinez-Gonzalez J. Incretin-raws li multi-agonists: structural design thiab receptor interaction profiles. Molecular Pharmacology. 2021;99(3):187-203.

3. Anderson PE, Kumar S, Davidson MB. Qhov ncauj bioavailability txhim kho cov tswv yim rau kev kho peptides. Pharmaceutical Research. 2023;40(1):112-134.

4. Wilson KR, Foster GD, Hampton JL. Central paj hlwb cuam tshuam ntawm metabolic peptides: kev noj qab haus huv cov cai thiab lub zog homeostasis. Neuroendocrinology. 2022; 114(6): 523-541.

5. Taylor RM, Johnson ML, Stevens AL. Lub cev muaj pes tsawg leeg cuam tshuam ntawm ntau- txoj hauv kev metabolic modulators: lean mass preservation thiab adipose ntaub so ntswg remodeling. Kev Tshawb Fawb Txog Kev Noj Qab Haus Huv thiab Kev Kho Mob . 2021; 15(5): 398-416.

6. Liu XY, Zhang WH, Park SJ. Glucagon receptor co-agonism nyob rau hauv metabolic peptides: ntsuas cov piam thaj tswj thiab kev siv hluav taws xob. Diabetes and Metabolism Journal. 2023;47(2):156-175.